tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 203 are a BUY (97.13%), 6 are a HOLD (2.87%).
Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 31.5% that have a potential upside of 41.58% achieved within 138 days.
Geulah Livshits’s has documented 369 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IMRX, Immuneering Corp at 13-Nov-2025.
Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) at 12/8/2020. The price target of $46 was fulfilled within 1 day with a profit of $13.97 (43.62%) receiving and performance score of 436.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$77
$26.77 (53.29%)
$82
14 days ago
(11-Nov-2025)
11/20 (55%)
$21.79 (39.47%)
196
Hold
$50
$-0.23 (-0.46%)
$42
14 days ago
(11-Nov-2025)
13/16 (81.25%)
$-5.21 (-9.44%)
152
Buy
$80
$29.77 (59.27%)
$81
16 days ago
(09-Nov-2025)
8/25 (32%)
$25.42 (46.57%)
214
Buy
$93
$42.77 (85.15%)
$78
1 months 9 days ago
(16-Oct-2025)
2/6 (33.33%)
$23.85 (34.49%)
32
Buy
$80
$29.77 (59.27%)
$80
2 months 3 days ago
(22-Sep-2025)
4/6 (66.67%)
$19.24 (31.67%)
100
Which stock is Geulah Livshits is most bullish on?
Which stock is Geulah Livshits is most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
